Cipla Latest News

  1. The Exchange has sought clarification from Cipla with respect to news article appearing on ET NOW on March 23, 2017 titled ‘USFDA issued import alert on Ciplas Tadalafil drug made at Bhagwanpur unit.’

    Date:23-03-2017
  2. The total consideration of transaction would be ZAR 375 million with potential revision linked to FY2017 performance along with customary adjustment
    Date:06-03-2017
  3. The company has entered into agreements to divest 100% stake in Cipla Agrimed and Cipla Vet
    Date:06-03-2017
  4. Cipla has informed about a Press Release dated February 17, 2017, titled ‘Cipla launches Hepatitis B vaccine in India’.

    The above information is a part of company’s filings submitted to BSE.

    ...
    Date:17-02-2017
  5. The company’s strong marketing network and reach will ensure maximum accessibility of the vaccines in India
    Date:17-02-2017
  6. The company’s strong marketing network and reach will ensure maximum accessibility of the vaccines in India
    Date:17-02-2017
  7. Total income of the company increased by 18.09% at Rs 3800.70 crore for the quarter under review
    Date:09-02-2017
  8. Cipla has informed that the Nomination and Remuneration Committee of the Company on February 08, 2017 allotted 39,691 equity shares of Rs 2 each pursuant to exercise of the stock options by the option grantees under Employee St...

    Date:08-02-2017
  9. Four M Propack ceases to be a subsidiary of GoldenCross with effect from February 01, 2017
    Date:03-02-2017
  10. Four M Propack ceases to be a subsidiary of GoldenCross with effect from February 01, 2017
    Date:02-02-2017
Return to Top
Connect with us Facebook
Connect with us Facebook
Connect with us Linkedin
Connect with us Pintrest
Connect with us Google Plus
Connect with us You Tube
Connect with us Mobile App
Request a Call Back
We will guide you on how to find
the Right stocks at the Right prices.
Mobile
Invalid Mobile Number
x
Thank you for
contacting us.
We will call you
shortly.